A new combination therapy is showing promise in reducing facial redness caused by rosacea, a common skin condition.

The India-based trial, the first of its kind, confirmed that systolic BP levels decreased no matter the exact mix of three ...

Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.

A 2002 study linked hormone therapy to a significant increased risk for breast cancer, but a follow-up study published in May ...

“We found that the probability of being alive and free of disease at two years was approximately 64% for cetuximab versus 51% ...

The observed changes were favorable, but results may have been affected by better-than-normal care in the control arm.

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Breztri Aerosphere® is a long-term medicine to treat COPD and give patients better breathing, improve COPD symptoms and ...

Denise Yardley, MD, discussed results with ribociclib in patients with early-stage breast cancer with no lymph node ...

"Dosing the first patient with Bria-OTS™ is a significant milestone for both BriaCell and cancer patients,” stated Giuseppe ...

Gliocidin selectively kills glioblastoma cells by inhibiting nucleotide synthesis, showing potential as a therapeutic option ...